A clinical review in Mayo Clinic Proceedings notes that GI effects are common across GLP-1 and related therapies
Specifically, in each of these cases, FDA was able to observe serious regulatory violations based only on a review of the companies websites and social media posts
Meta-analyses confirmed that semaglutide was accompanied by numeric improvements in these lipid-related indicators compared with placebo, with the exception of HDL (Figure 10, Supplementary Figures S9S13, Supplementary Table S3)
When GLP-1R is stimulated, various downstream signaling pathways become activated, including cAMP/PKA, cAMP/Epac/PI3K/Akt, and ERK/MAPK
It is also important to monitor overall mineral status during any prolonged detoxification protocol